Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01CX001848-01 |
| Title: | Microbiologic impact of medical therapies for recurrent Clostridium difficile infection |
| Principal Investigator: | Curtis J. Donskey |
| Location: | Cleveland, OH |
| Congressional District Code: | 11 |
| Research Service: | Clinical Science R&D; |
| Project Period: | April 2019 - March 2023 |
| FY 2021 Funding Amount: | $165,000 |
| Total Award Amount (all years): |
$762,500 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Approximately 25% of patients responding to treatment for initial cases of Clostridium difficile infection (CDI) develop a recurrence of the infection, and many develop multiple recurrences. Unfortunately, the optimal medical management of recurrent CDI is unclear. In particular, vancomycin taper and pulse regimens are commonly used, but have not been compared to other medical treatments in randomized trials. To address this deficiency, the VA Cooperative Studies Program (CSP) is conducting a ra... |